Intradiscal vacuum phenomenon and spinal degeneration: a cross-sectional analysis of 219 subjects [0.03%]
盘内真空现象与脊柱退变：219例患者的横断面分析
Murat Şakir Ekşi,Emel Ece Özcan-Ekşi,Alper Akkaş et al.
Murat Şakir Ekşi et al.
Introduction: Intradiscal vacuum phenomenon (IVP) is the collection of gas within the intervertebral discs. It has been reported with various spinal disorders. The exact role of IVP in spinal degeneration leading to low b...
Knowledge, attitude, perceived barriers, and practices among pharmacists regarding risk assessment of cardiovascular disease: a cross-sectional study in Yemen [0.03%]
药师对心血管疾病风险评估的知识，态度，感知障碍和行为的实践：也门的一项横断面研究
Fahmi Y Al-Ashwal,Syed Azhar Syed Sulaiman,Siti Maisharah Sheikh Ghadzi et al.
Fahmi Y Al-Ashwal et al.
Background: Risk evaluation of atherosclerotic cardiovascular diseases can guide the decision-making on various preventive measures, such as initiating or deferring statin therapy. Pharmacists can play an active part in t...
Retrospective descriptive analysis of a managed care population with obesity [0.03%]
肥胖Managed Care人群的回顾性描述分析
Andrew Osterland,Claire King,Neela Kumar et al.
Andrew Osterland et al.
Objectives: To reveal the extent of obesity in a single healthcare system and provide a blueprint for other health systems to perform similar analyses, this study describes characteristics and weight change patterns of pa...
Observational Study
Current medical research and opinion. 2022 Jan;38(1):83-89. DOI:10.1080/03007995.2021.1991900 2022
Combination anticoagulant or P2Y12 inhibitor with low-dose aspirin versus low-dose aspirin alone in patients at risk or with documented coronary and/or peripheral artery disease [0.03%]
低剂量阿司匹林联合抗凝剂或P2Y12抑制剂与仅使用低剂量阿司匹林在有冠状动脉和/或外周动脉疾病风险或已证实的患者中的比较研究
Craig I Coleman,Akshay A Kharat,Brahim Bookhart et al.
Craig I Coleman et al.
Objective: To perform a systematic literature review and indirect treatment comparison (ITC) to identify, summarize and quantify randomized controlled trial (RCT) evidence evaluating combination anticoagulant or P2Y12 inh...
Cost-effectiveness of tapentadol immediate release versus oxycodone immediate release for acute post-operative pain after major hip surgeries [0.03%]
全髋关节置换术后急性术后疼痛使用盐酸戊乙奎醚与羟考酮的费用效果分析
Xinyi Wang,Jonathan Penm,Asad E Patanwala
Xinyi Wang
Objective: To evaluate the cost-effectiveness of tapentadol immediate-release (IR) versus oxycodone IR for post-operative pain after a major hip surgery. ...
A survey of physicians' treatment switching practice in people on long-term prophylaxis for hemophilia in five European countries [0.03%]
对欧洲五国长期接受血友病预防治疗的患者中医生更换治疗方法行为的调查研究
Marijn van der Sluijs,Nicole Huyghe,Caroline Wood et al.
Marijn van der Sluijs et al.
Objective: Recombinant factor VIII and factor IX Fc fusion proteins (rFVIIIFc and rFIXFc) were developed with an extended half-life (EHL) to improve the management of people with hemophilia A (PwHA) and B (PwHB), respecti...
The burden of undertreatment and non-treatment among patients with non-valvular atrial fibrillation and elevated stroke risk: a systematic review [0.03%]
具有卒中高风险的非瓣膜性房颤患者的治疗不足和不治疗负担：系统回顾
Matthew Sussman,Geoffrey D Barnes,Jennifer D Guo et al.
Matthew Sussman et al.
Objective: Global treatment guidelines recommend treatment with oral anticoagulants (OACs) for patients with non-valvular atrial fibrillation (NVAF) and an elevated stroke risk. However, not all patients with NVAF and an ...
Prevalence of drug-induced constipation and severity of associated biopsychosocial effects in patients with nonmalignant pain: a cross-sectional review of depersonalized data from the German Pain e-Registry [0.03%]
非恶性疼痛患者药物引起便秘的患病率及相关的生物心理社会影响的严重程度：来自德国疼痛电子登记处数据的横断面回顾
Michael A Ueberall,Ute Essner,Gerhard Müller-Schwefe et al.
Michael A Ueberall et al.
Background: Drug-induced constipation (DIC) is a well-known comorbidity of cancer pain, however, data on its prevalence in nonmalignant pain (NMP) and its biopsychosocial effects are few. ...
Correction [0.03%]
更正
Adherence and persistence to rivaroxaban in non-valvular atrial fibrillation patients receiving 30- or 90-day supply prescription fills [0.03%]
接受30或90天药量的非瓣膜性房颤患者对利伐沙班的依从性和持续用药率
Craig I Coleman,Thomas J Bunz,Veronica Ashton
Craig I Coleman
Background: It is unclear whether 90-day supply fills with rivaroxaban result in better adherence and persistence compared to 30-day supply fills. We assessed patients' adherence and persistence to rivaroxaban at 12- and ...